EX-21 2 v18599exv21.htm EXHIBIT 21 exv21
 

EXHIBIT 21
DIAGNOSTIC PRODUCTS CORPORATION AND SUBSIDIARIES
EXHIBIT 21 — SUBSIDIARIES
             
    Place of    
Name   Incorporation   % Ownership
DPC Cirrus, Inc.
  USA/Delaware     100 %
EURO/DPC Limited
  United Kingdom     100 %
Diagnostic Products International Inc.
  Barbados     100 %
DPC Analytic
  Slovenia     100 %
DPC Holding GmbH
  Germany     100 %
DPC Biermann GmbH
  Germany     100 %
DPC Czech s.r.o.
  Czech Republic     100 %
DPC d.o.o. Zagreb
  Croatia     50 %
DPC Polska sp.z.o.o.
  Poland     100 %
DPC Slovensko
  Slovakia     100 %
DPC Benelux B.V.
  Netherlands     100 %
DPC Nederland B.V.
  Netherlands     100 %
DPC Belgium b.v.b.A./s.p.r.l.
  Belgium     100 %
DPC Finland OY
  Finland     100 %
Bio-Mediq DPC Pty. Ltd.
  Australia     100 %
DPC Dipesa S.A.
  Spain     100 %
DPC France SAS
  France     100 %
Tianjin De Pu (DPC) Biotechnological and Medical Products Inc.
  China     100 %

1

 

EXHIBIT 21
DIAGNOSTIC PRODUCTS CORPORATION AND SUBSIDIARIES
EXHIBIT 21 – SUBSIDIARIES (CONTINUED)
             
    Place of    
Name   Incorporation   % Ownership
Diagnostic Products DPC Norway A/S
  Norway     100 %
DPC Medlab
  Bolivia     28 %
DPC Medlab Productos Medico Hospitalares Ltda.
  Brazil     56 %
DPC MEDLAB BRAZIL
  Brazil     56 %
DPC Medlab Productos Medico Hospitalares Ltda.
  Dominican Republic     56 %
DPC Venezuela C.A.
  Venezuela     56 %
DPC Medlab de Uruguay S.A.
  Uruguay     56 %
DPC Medlab Panama, S.A.
  Panama     29 %
DPC Medlab Guatemala
  Guatemala     29 %
DPC Medlab Centroamerica S.A.
  Costa Rica     29 %
Nippon DPC Corporation
  USA/California     50 %
DPC Scandinavia AB
  Sweden     100 %
DPC Baltic Estonia OU
  Sweden     100 %
DPC Baltic Latvia SIA
  Sweden     100 %
DPC Baltic UAB Lithuania
  Sweden     100 %
D.P.C.-N. Tsakiris S.A.
  Greece     50 %
Medical Systems S.p.A.
  Italy     45 %
DPC Amerlab Lda.
  Portugal     47.5 %
Lumigen, Inc.
  U.S.A./Michigan     10 %

2